zepbound novo nordisk - Search News

News

CEO of Novo Nordisk, Maker of Weight Loss Drug Wegovy

The New York Times · 1h

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Associated Press News on MSN · 49m

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

CBS News on MSN · 59m

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."

3d

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

Novo Nordisk CEO Jørgensen to Depart With Danish Pharma’s Shares in Freefall

Over his eight years as CEO, Novo’s sales, profits and share price have almost tripled, the company said. However, the shares ...

2don MSN

Novo Nordisk strikes $2.2 billion deal with Septerna to develop new obesity treatments

Novo Nordisk has struck a collaboration and licensing deal with U.S. biotech Septerna to develop oral small molecule ...

4don MSN

Here’s how much extra weight is lost with Zepbound over Wegovy

A study of two blockbuster weight-loss drugs showed that users of Eli Lilly’s Zepbound lost just over 2 inches more off their ...

3hon MSN

Here’s Why Polen Focus Growth Strategy Exited Novo Nordisk A/S (NVO)

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first quarter 20245 investor ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results